Noemí Rotllán

Macrophage-Derived 25-Hydroxycholesterol Promotes Vascular Inflammation, Atherogenesis, and Lesion Remodeling

Loss of hepatic miR-33 improves metabolic homeostasis and liver function without altering body weight or atherosclerosis

Absence of ANGPTL4 in adipose tissue improves glucose tolerance and attenuates atherogenesis

Genetic Ablation of miR-33 Increases Food Intake, Enhances Adipose Tissue Expansion, and Promotes Obesity and Insulin Resistance

Inflammatory Ly6Chi monocytes and their conversion to M2 macrophages drive atherosclerosis regression

MicroRNAs and lipid metabolism

Genetic Dissection of the Impact of miR-33a and miR-33b during the Progression of Atherosclerosis

ANGPTL4 deficiency in haematopoietic cells promotes monocyte expansion and atherosclerosis progression

Chronic miR‐29 antagonism promotes favorable plaque remodeling in atherosclerotic mice

MicroRNA-148a regulates LDL receptor and ABCA1 expression to control circulating lipoprotein levels

Akt‐mediated foxo1 inhibition is required for liver regeneration

Genetic Evidence Supports a Major Role for Akt1 in VSMCs During Atherogenesis

Autoregulation of glypican-1 by intronic microRNA-149 fine-tunes the angiogenic response to fibroblast growth factor in human endothelial cells

Control of Cholesterol Metabolism and Plasma High-Density Lipoprotein Levels by microRNA-144

Therapeutic Silencing of MicroRNA-33 Inhibits the Progression of Atherosclerosis in <i>Ldlr</i> ^−/− Mice—Brief Report

MicroRNA 33 Regulates Glucose Metabolism

MicroRNAs and Atherosclerosis

MicroRNA modulation of lipid metabolism and oxidative stress in cardiometabolic diseases

Cardiovascular dysregulation of miR‐17‐92 causes a lethal hypertrophic cardiomyopathy and arrhythmogenesis

MicroRNA Regulation of Cholesterol Metabolism

Gain-of-Function Lipoprotein Lipase Variant rs13702 Modulates Lipid Traits through Disruption of a MicroRNA-410 Seed Site